Guidance

Patient Involvement Strategy

Our Patient Involvement Strategy sets out how we will engage and involve the public and patients at every step of the regulatory journey.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 1 October 2021

Documents

Patient Involvement Strategy 2021-25

HTML

Patient Involvement Strategy 2021-25

PDF, 1.25 MB, 11 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

In developing the strategy, we have started as we mean to continue. Our approach was informed at the very outset through consultation with patients on what was important to them. The Independent Medicines and Medical Devices Safety Review also provided us with clear direction on where we could improve our engagement with patients, and the resulting strategy was then approved by our Patient Safety and Engagement Committee and Agency Board.

We wanted to be sure that the strategy resonated with patients too, conducting a final public consultation on the strategy to identify any areas that we needed to adapt, or that we had overlooked. This step allowed us to make some further additions to our approach and we will continue to listen to patients throughout as we deliver it.

We recognise that these are the first steps on an ambitious journey, and that its successful delivery lies in the engagement and involvement of the public, patients and other health sector organisations as partners, with us on the journey.

Published 1 October 2021